Therapy News and Research

RSS

Using molecular targeting approach to kill melanoma cells

In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.

27 Nov 2018

$UA scientist hopes to heal bone fractures using combination of 3D printing and adult stem cells$

UA scientist hopes to heal bone fractures using combination of 3D printing and adult stem cells

Not all broken bones heal. But one scientist at the University of Arizona hopes to remedy that problem using a combination of 3D printing and adult stem cells.

27 Nov 2018

ICUS applauds announcement of dramatic changes in payment for contrast-enhanced ultrasound imaging

The International Contrast Ultrasound Society (ICUS) applauds the announcement of dramatic changes in payment for contrast-enhanced ultrasound (CEUS) imaging of the abdomen.

27 Nov 2018

Study: Measuring and monitoring tumor DNA can help reveal early melanoma growth

Researchers at the Johns Hopkins Kimmel Cancer Center say they have added to evidence that measuring and monitoring tumor DNA that naturally circulates in the blood of melanoma patients can not only reliably help reveal the early stages of cancer growth and spread but also uncover new treatment options that tumor genetic analysis alone may not.

27 Nov 2018

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Some severe forms of leukemia develop because proteins on the epigenetic level lose their regulative function. Now, in a broad international collaboration, UK researchers have identified molecules that can effectively inhibit the dysregulated proteins.

27 Nov 2018

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).

27 Nov 2018

UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

UC San Francisco scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies.

27 Nov 2018

BIO issues statement on proposed changes to Medicare Part D and Medicare Advantage plans

BIO President and CEO Jim Greenwood issued the following statement regarding today's proposed changes to Medicare Part D and Medicare Advantage plans.

26 Nov 2018

Robots could help improve social skills of children with ASD

An emotionally intelligent, partially autonomous social robot could help children with autism spectrum disorder improve their social skills, according to EU-funded researchers who have been developing the next generation of robot-enhanced therapy.

26 Nov 2018

Genetic risk score for autism linked with outcomes of psychological treatment

Depression is a common disorder for which cognitive behavioral therapy is the recommended treatment for most patients.

26 Nov 2018

Gut-directed hypnotherapy may offer new treatment option for IBS patients

Gut-directed hypnotherapy delivered by psychologists appears as effective in group or individual sessions, potentially offering a new treatment option for irritable bowel syndrome in primary and secondary care.

23 Nov 2018

Cognitive behavioral therapy is cost-effective and reduces anxiety symptoms in COPD patients

Cognitive behavioral therapy delivered by respiratory nurses is cost-effective and reduces anxiety symptoms in chronic obstructive pulmonary disease patients, according to research published in ERJ Open Research.

23 Nov 2018

MERS virus that causes harmless cold in camels can be fatal for humans

What causes only a harmless cold in camels can be fatal for humans: an infection with the MERS virus. Since its discovery in 2012, the virus was detected in approximately 2,000 patients and 36 percent of them have not survived the severe lung disease known as MERS.

22 Nov 2018

AI and Big Data enable better diagnosis, personalized treatment of eye diseases

"Exactly one year ago, we spoke about the fact that, in future, it will be possible to diagnose diabetes from the eye using automatic digital retinal screening, without the assistance of an ophthalmologist – 12 months on, MedUni Vienna is right in the middle of this digital revolution." These were the words used by Ursula Schmidt-Erfurth, Head of MedUni Vienna's Department of Ophthalmology and Optometrics to open today's press conference about the ART-2018 Specialist Meeting on new developments in retinal therapy, which is to take place on 1 December.

22 Nov 2018

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

One of the most successful techniques to combat multidrug resistance in cancer cells is the downregulation of those genes responsible for drug resistance.

22 Nov 2018

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Mannose sugar, a nutritional supplement, can both slow tumor growth and enhance the effects of chemotherapy in mice with multiple types of cancer.

21 Nov 2018

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Mannose, a type of sugar, has been shown to slow tumor growth and enhance chemotherapy in mouse models of certain cancers.

21 Nov 2018

Brain imaging study reveals 'hot spot' for cue-reactivity in substance users

When patients with dependence on alcohol, cocaine or nicotine are shown drug cues, or images related to the substance, an area of their brain known as the medial prefrontal cortex shows increased activity, report investigators at the Medical University of South Carolina in an article published online September 7, 2018 in Translational Psychiatry.

21 Nov 2018

Researchers awarded $7 million funding in Pancreatic Cancer Collective’s 'New Therapies Challenge'

The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer, has awarded a total of $7 million in first-round "New Therapies Challenge" grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced today.

21 Nov 2018

Stand Up to Cancer supports potential approach to more efficiently target pancreatic cancer

Research on a new way of deploying the immune system against pancreatic cancer, an exceptionally lethal cancer that has so far resisted new immunotherapies, will receive $1 million in initial funding from Stand Up to Cancer.

21 Nov 2018

Therapy News and Research

Using molecular targeting approach to kill melanoma cells

UA scientist hopes to heal bone fractures using combination of 3D printing and adult stem cells

ICUS applauds announcement of dramatic changes in payment for contrast-enhanced ultrasound imaging

Study: Measuring and monitoring tumor DNA can help reveal early melanoma growth

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

BIO issues statement on proposed changes to Medicare Part D and Medicare Advantage plans

Robots could help improve social skills of children with ASD

Genetic risk score for autism linked with outcomes of psychological treatment

Gut-directed hypnotherapy may offer new treatment option for IBS patients

Cognitive behavioral therapy is cost-effective and reduces anxiety symptoms in COPD patients

MERS virus that causes harmless cold in camels can be fatal for humans

AI and Big Data enable better diagnosis, personalized treatment of eye diseases

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Brain imaging study reveals 'hot spot' for cue-reactivity in substance users

Researchers awarded $7 million funding in Pancreatic Cancer Collective’s 'New Therapies Challenge'

Stand Up to Cancer supports potential approach to more efficiently target pancreatic cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News